Get App Open
In App
Lending
Lending
Open App
you are here:

Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 10, 16:01
903.75 22.05 (2.50%)
Volume
AVERAGE VOLUME
5-Day
17,800
10-Day
17,817
30-Day
23,635
21,149
  • Prev. Close

    881.70

  • Open Price

    881.75

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 10, 15:59
904.75 23.25 (2.64%)
Volume
AVERAGE VOLUME
5-Day
249,599
10-Day
282,567
30-Day
675,950
496,440
  • Prev. Close

    881.50

  • Open Price

    881.50

  • Bid Price (Qty.)

    904.75 (5)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Cohance Lifesciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,172.28 1,035.85 1,331.11 1,307.01 995.46  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,172.28 1,035.85 1,331.11 1,307.01 995.46  
Total Operating Revenues 1,197.58 1,051.35 1,340.33 1,320.22 1,009.72  
Other Income 58.56 61.91 46.36 92.38 14.24  
Total Revenue 1,256.14 1,113.26 1,386.69 1,412.60 1,023.96  
EXPENSES  
Cost Of Materials Consumed 222.66 265.88 430.08 459.46 310.32  
Purchase Of Stock-In Trade 0.00 0.00 0.00 0.00 0.00  
Operating And Direct Expenses 0.00 133.48 176.29 173.19 122.73  
Changes In Inventories Of FGWIP And Stock In Trade 82.63 49.16 -20.94 -60.35 -8.37  
Employee Benefit Expenses 249.56 135.92 110.51 100.48 87.29  
Finance Costs 12.35 7.45 5.44 6.23 9.14  
Depreciation And Amortisation Expenses 77.49 54.60 47.73 39.10 31.64  
Other Expenses 267.53 61.11 77.86 68.02 57.27  
Total Expenses 912.22 707.59 826.96 786.12 610.02  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 343.92 405.67 559.73 626.48 413.94  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 343.92 405.67 559.73 626.48 413.94  
Tax Expenses-Continued Operations  
Current Tax 86.77 99.58 146.27 190.40 101.54  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -14.19 6.59 4.34 23.38 3.62  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 79.15 105.39 148.44 213.79 105.33  
Profit/Loss After Tax And Before ExtraOrdinary Items 264.77 300.28 411.29 412.69 308.61  
Profit/Loss From Continuing Operations 264.77 300.28 411.29 412.69 308.61  
Profit/Loss For The Period 264.77 300.28 411.29 412.69 308.61  
Minority Interest 3.10 0.00 0.00 0.00 0.00  
Consolidated Profit/Loss After MI And Associates 267.87 300.28 411.29 453.80 362.34  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 11.00 12.00 16.00 18.00 14.00  
Diluted EPS (Rs.) 10.00 12.00 16.00 18.00 14.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 203.65 101.83 25.46  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970